8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 5,470,174 | $457,138,134 | +18% | 1.8% |
| 2. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 271,000 | $22,709,800 | +43% | 2.29% |
| 3. | Bailard Inc Thomas Bailard | 203,755 | $17,074,669 | +20% | 0.44% |
| 4. | Running Oak Capital Seth Cogswell | 163,321 | $13,686,301 | +3% | 1.85% |
| 5. | 2,800 | $234,612 | +4% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.98 | 25,000 | Director | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | Director | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | Director | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | Director | 32,294 | 2017-04-24 | Filing | |
| $16.49 | 30,000 | Director | 41,598 | 2016-02-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.94 | 82,085 | Officer, Director | 1,572,096 | 2024-10-07 | Filing | |
| $84.31 | 80,692 | Officer, Director | 1,654,181 | 2024-10-07 | Filing | |
| $85.00 | 132,527 | Officer | 160,467 | 2024-10-07 | Filing | |
| $83.86 | 6,983 | Officer | 34,748 | 2024-10-01 | Filing | |
| $81.17 | 162,777 | Officer, Director | 1,622,987 | 2024-09-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 138,250,950 | $7,992,287,449 | 0.61% | |
| 2. | 126,559,832 | $7,316,423,899 | 0.18% | |
| 3. | 125,449,802 | $7,252,253,054 | 0.15% | |
| 4. | 62,334,606 | $3,603,563,573 | 0.17% | |
| 5. | 57,175,970 | $3,305,342,824 | 1.06% |
News See All
Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Boston Scientific Corporation (BSX) Surged on Excitement Over the Launch of its Ablation System
Janus Henderson Investors, an investment management company, released its “Janus Henderson Enterprise Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
7 Best Medical Device Stocks To Buy Right Now
The global medical devices market is experiencing robust growth, driven by technological advancements, an aging population, and an increasing prevalence of chronic diseases.
7 Best Dialysis and Kidney Disease Stocks to Buy
The global kidney treatment and dialysis market is experiencing typical growth levels.
10 Best Healthcare Stocks To Buy According to Hedge Funds
Investing in healthcare equities is typically seen as protective during difficult economic times.
Morgan Stanley's Best Stock Picks: 15 Stocks To Own For 2025
The tail end of 2024 is seeing a market shift in the stock market as the Federal Reserve has finally signaled that interest rate cuts are on the horizon.
10 Best Blue Chip Stocks Under $100
The re-acceleration (or the no-landing) case is being advocated by strong job growth, healthy double-digit expectations for growth in corporate earnings, and inflation remaining above 2.5%.
What Makes Boston Scientific Corporation (BSX) a Compelling Investment?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Boston Scientific Corporation (NYSE:BSX) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific Second Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions].
Billionaire Hedge Funds
